Skip to main content

Bioinstrumentation Sector Poised to Grow 15% in 2001

NEW YORK, Jan 22 – The bioinstrumentation sector is forecast to grow 15 percent this year to $4.3 billion, Strategic Directions International, a market research and consulting firm that tracks the instrument industry, said in a recent edition of its Instrument Business Outlook report.

Bioinstrumentation accounts for nearly 20 percent of all analytical instrument sales, SDI said. According to SDI bioinstrumentation includes all instruments for DNA sequencing, nucleic acid amplification, synthesis, electrophoresis and flow cytometry, as well as microarrays and biosensors.  

Academics, pharmaceutical companies, and biotech firms are the leading users of bioinstrumentation. SDI noted that the DNA sequencers and microarrays are among the fastest growing markets.

SDI publishes the Instrument Business Outlook twice a month.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.